Hybrid Biotechnology CRO · Kolkata, India
We build medical knowledge through human biospecimen biobanking and prospective clinical trials — supported by our reference lab, Indopath Clinical — to accelerate drug development at international standards.
What we do
A hybrid model that lets partners decide what to manage in-house and what to entrust to us — with data and biospecimens flowing between both.
An exhaustive biorepository of high-quality, well-characterized human biospecimen samples and data — readily available for research into cancer, cardiovascular disease, diabetes and other complex conditions, coupling cryogenically preserved samples with rich subject data.
Discover the biobankAs a hybrid CRO, patient safety and confidentiality come first. Choose which parts of the clinical trial lifecycle to manage yourself and which to contract to us — a model customised to your requirements across every phase of drug development.
See how it worksThe hybrid advantage
Our model puts you in control of the clinical drug development life cycle. Keep the parts you do best; hand us the rest. Every engagement is shaped around your protocol, your timelines, and your quality bar.
Manage services yourself or contract them out — a flexible split that adapts as your programme evolves.
Biobank samples and reference-lab data from Indopath Clinical feed directly into your evidence base.
A clean audit history with USFDA and DCGI underpins every site we manage.
By the numbers
clinical trial projects across various indications
of continuous biobanking operations
clinical trials conducted end-to-end
Form 483 findings across USFDA audits
India carries 18% of the global disease burden but hosts under 2% of the world's clinical trials. Organised site management is how we bridge that divide.
Chain of custody
Every biospecimen is tracked from informed consent to research release — temperature-controlled, fully documented, and auditable at each step.
Unbroken cold chain · 24/7 monitored
Informed consent is captured before anything is drawn, and each specimen is barcoded to its donor record at the bedside.
Donor-matchedQualified shippers and continuous data loggers move the sample without a single excursion from collection to lab.
Logged end to endAliquoting, annotation and quality control in our reference lab — so every vial carries a complete data profile.
QC releasedVapour-phase liquid nitrogen at −196 °C, alarmed and monitored around the clock with backup power.
−196 °CMatched to a study protocol and released to partners with its full provenance record intact.
Full provenanceInsights & Publications
Biobanking in India is gaining momentum. A look at how modern biospecimen banks function and why now is the moment to pay attention.
Read moreWhat clinical research sites really do, and why the right site is the foundation of any trial that reaches the market.
Read moreGrit, discipline and perseverance — the three things our founder swears by, and the story of how Indoriv came to be.
Read more
